Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Total or Subtotal Colectomy in Stage IIIC and Stage IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (EOC, FTC, PPC)

NCT02595021 is registered in ClinicalTrials.gov with Shanghai Gynecologic Oncology Group as lead sponsor.

NCT NCT02595021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02595021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Total or Subtotal Colectomy in Stage IIIC and Stage IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (EOC, FTC, PPC)
Lead sponsor
Shanghai Gynecologic Oncology Group
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2015
Completion date
December 31, 2018
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer, fallopian tube cancer, primary peritoneal carcinoma, secondary malignant neoplasm of large intestine